UGM 2007 Uji Pra-Klinis untuk ND-60
Aim
This study aims to conduct a Preclinical Test of NUTRIGOLD D as an antidiabetic through the understanding of the effect of NUTRIGOLD D on serum glucose levels of hyperglycemic male white rats (Sprague Dawley). While also observing the pancreatic function for both Diabetes Mellitus type I and II.
Research Team
Protector: Dean of the Faculty of Pharmacy UGM, Yogyakarta, Dr. Marchaban, DESS, Apt
Person responsible: Head of Pharmacology & Toxicology Laboratory, Faculty of Pharmacy UGM,
Yogyakarta, Prof., Lukman Hakim, MSc, PhD, Apt
Member: Arief Rahman Hakim, MSi., Apt, Nunung Yuniarti, S.F., MSi., Apt
Conclusion
The administration of NUTRIGOLD D at a dose of 604.8 mg/kg BW and 1209.6 mg/kg BW have the potential to reduce serum glucose levels in male Sprague Dawley mice with pathological conditions resembling Diabetes Mellitus type I, however, the process is deemed to be a long term medication.